Catalog #
  • ---All---
  • Accession
  • Catalog #

EphB2 Antibody (N-term)Purified Rabbit Polyclonal Antibody (Pab)

United States
Albania Australia Austria Belgium Bosnia & Herzegovina Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hong Kong Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands New Zealand Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia South Africa Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP7623a 400 µl In Stock $ 265.00 Add to cart
AP7623a-ev 80 µl In Stock $ 95.00 Add to cart
  • Specification
  • Citations : 1
  • Reviews
  • Protocols
  • Background

EphB2 Antibody (N-term) - Product info

  • Applications Legend:
  • WB=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • FC=Flow Cytometry
  • DB=Dot Blot
Primary AccessionP29323
ReactivityHuman, Mouse
IsotypeRabbit Ig
Calculated MW117493 Da

EphB2 Antibody (N-term) - Additional info

Gene ID 2048
Other Names
EPHB2; DRT; EPHT3; EPTH3; ERK; HEK5; TYRO5; Ephrin type-B receptor 2; Developmentally-regulated Eph-related tyrosine kinase; ELK-related tyrosine kinase; EPH tyrosine kinase 3; EPH-like kinase 5; Renal carcinoma antigen NY-REN-47; Tyrosine-protein kinase TYRO5; Tyrosine-protein kinase receptor EPH-3
This EphB2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 103-133 amino acids from the N-terminal region of human EphB2.
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
EphB2 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures.

EphB2 Antibody (N-term) - Protein Information

Name EPHB2
Synonyms DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5
Receptor tyrosine kinase which binds promiscuously transmembrane ephrin-B family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Functions in axon guidance during development. Involved in the guidance of commissural axons, that form a major interhemispheric connection between the 2 temporal lobes of the cerebral cortex. Also involved in guidance of contralateral inner ear efferent growth cones at the midline and of retinal ganglion cell axons to the optic disk. Beside axon guidance, also regulates dendritic spines development and maturation and stimulates the formation of excitatory synapses. Upon activation by EFNB1, abolishes the ARHGEF15-mediated negative regulation on excitatory synapse formation. Controls other aspects of development including angiogenesis, palate development and in inner ear development through regulation of endolymph production. Forward and reverse signaling through the EFNB2/EPHB2 complex regulate movement and adhesion of cells that tubularize the urethra and septate the cloaca. May function as a tumor suppressor.
Cellular Location
Cell membrane; Single-pass type I membrane protein. Cell projection, axon (By similarity). Cell projection, dendrite (By similarity)
Tissue Location
Brain, heart, lung, kidney, placenta, pancreas, liver and skeletal muscle. Preferentially expressed in fetal brain

EphB2 Antibody (N-term) - Related products

AM7623b: EPHB2 Antibody

AP7623b: EphB2 Antibody (C-term)

AP7623d: EphB2 Antibody

BP7623b: EphB2 Antibody (C-term) Blocking Peptide

AO1163a: EphB2 Antibody

AN1086: Phospho-Tyr317 EphrinB Antibody

AN1087: Phospho-Tyr331 EphrinB Antibody

AN1088: Phospho-Tyr298 EphrinB Antibody

EphB2 Antibody (N-term) - Application data

  • EphB2 Antibody (N-term)(Cat. #AP7623A)immunohistochemistry analysis in formalin fixed and paraffin embedded human skeletal muscle followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of EphB2 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.

  • EphB2 Antibody (N-term)(Cat. #AP7623A)immunohistochemistry analysis in formalin fixed and paraffin embedded human skeletal muscle followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of EphB2 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.

EphB2 Antibody (N-term) - Research Areas

AntibodiesGene OntologyBiological ProcessCell DifferentiationNeurogenesisOrgan DevelopmentProtein Amino Acid PhosphorylationPost-translational Protein ModificationPhosphate Metabolic ProcessPhosphorus Metabolic ProcessPhosphorylationProtein Modification ProcessBiopolymer ModificationMetabolic ProcessPrimary Metabolic ProcessProtein Metabolic ProcessCellular Protein Metabolic ProcessCellular Metabolic ProcessCellular ProcessPositive Regulation Of Biological ProcessPositive Regulation Of Cellular ProcessNegative Regulation Of Cellular ProcessNegative Regulation Of Biological ProcessSystem DevelopmentMacromolecule Metabolic ProcessMulticellular Organismal DevelopmentAnatomical Structure DevelopmentEnzyme Linked Receptor Protein Signaling PathwayDevelopmental ProcessCellular Macromolecule Metabolic ProcessRegulation Of Biological QualityPeptidyl-amino Acid ModificationAnatomical Structure MorphogenesisRegulation Of Cell CommunicationTransmembrane Receptor Protein Tyrosine Kinase Signaling PathwayRegulation Of Multicellular Organismal ProcessOrgan MorphogenesisNervous System DevelopmentGeneration Of NeuronsRegulation Of Developmental ProcessCellular Component OrganizationPositive Regulation Of Developmental ProcessCellular Developmental ProcessNeuron DifferentiationCell DevelopmentCentral Nervous System DevelopmentRegulation Of Cell DifferentiationCamera-type Eye MorphogenesisPeptidyl-tyrosine ModificationSensory Organ DevelopmentPeptidyl-tyrosine PhosphorylationCell MotionBiological RegulationRegulation Of Cellular Component OrganizationRegulation Of System ProcessNegative Regulation Of Developmental ProcessCamera-type Eye DevelopmentNeuron DevelopmentPositive Regulation Of Cell DifferentiationNeuron Projection DevelopmentRegulation Of Biological ProcessEye MorphogenesisEye DevelopmentMulticellular Organismal ProcessLearning Or MemoryResponse To StimulusCell Projection OrganizationRegulation Of Transmission Of Nerve ImpulseRegulation Of Neurological System ProcessRegulation Of Synaptic PlasticityRegulation Of Synaptic TransmissionNegative Regulation Of Cell DifferentiationRegulation Of Anatomical Structure MorphogenesisRegulation Of Cellular ProcessRegulation Of Cell DevelopmentNeuron Projection MorphogenesisAxonogenesisRegulation Of Neuronal Synaptic PlasticityCell Morphogenesis Involved In DifferentiationNegative Regulation Of Cellular Component OrganizationCell Morphogenesis Involved In Neuron DifferentiationPositive Regulation Of Cell DevelopmentCell MorphogenesisCellular CompartmentIntegral To Plasma MembraneIntrinsic To Plasma MembraneCell SomaPlasma Membrane PartMolecular FunctionCatalytic ActivityKinase ActivityPhosphotransferase Activity, Alcohol Group As AcceptorProtein Kinase ActivityTransferase Activity, Transferring Phosphorus-containing GroupsTransferase ActivityProtein BindingPurine Nucleotide BindingNucleotide BindingRibonucleotide BindingPurine Ribonucleotide BindingPurine Nucleoside BindingNucleoside BindingAdenyl Nucleotide BindingATP BindingAdenyl Ribonucleotide BindingProtein Tyrosine Kinase ActivityTransmembrane Receptor Protein Tyrosine Kinase ActivityReceptor BindingEphrin Receptor ActivityPathwaysKEGGRenal Cell CarcinomaPantherAngiogenesisDiseaseProstate CancerTissuePlacentaBrainEpitheliumRenal Cell Carcinoma
  • EphrinB2 and EphB4 expression in pterygia: new insights and preliminary results. Author : Xue C, Huang Z, Wang J, Dong Y, Zhou X.
    Can J Ophthalmol. 2009 Apr;44(2):185-8. doi: 10.3129/i09-005.
    PubMed® Id : 19491953

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at

Thank you for your support.


Provided below are standard protocols that you may find useful for product applications.


Ephrin receptors and their ligands, the ephrins, mediate numerous developmental processes, particularly in the nervous system. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase (RTK) family. The ligand-activated form of EphB2, which belongs to the Tyr family of protein kinases, interacts with multiple proteins, including GTPase-activating protein (RASGAP) through its SH2 domain. It binds RASGAP through the juxtamembrane tyrosines residues, and also interacts with PRKCABP and GRIP1 This type I membrane protein is expressed in brain, heart, lung, kidney, placenta, pancreas, liver and skeletal muscle. It is preferentially expressed in fetal brain. This protein contains putatively 2 fibronectin type III domains and 1 sterile alpha motif (SAM) domain.


Thanos, C.D., et al., Science 283(5403):833-836 (1999).
Tang, X.X., et al., Oncogene 17(4):521-526 (1998).
Fox, G.M., et al., Oncogene 10(5):897-905 (1995).
Ikegaki, N., et al., Hum. Mol. Genet. 4(11):2033-2045 (1995).
Iwase, T., et al., Biochem. Biophys. Res. Commun. 194(2):698-705 (1993).